Shaocong Wu
State Key Laboratory Of Oncology In South China, P.R. China
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis.
Journal: Signal transduction and targeted therapy
Published: July 10, 2023
A20 promotes colorectal cancer immune evasion by upregulating STC1 expression to block "eat-me" signal.
Journal: Signal transduction and targeted therapy
Published: February 10, 2023
Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer.
Journal: ImmunoTargets and therapy
Published: May 18, 2022
Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo.
Journal: Molecular therapy oncolytics
Published: June 09, 2021
PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma.
Journal: Acta pharmaceutica Sinica. B
Published: January 03, 2021
Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 06, 2020
Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer.
Journal: Signal transduction and targeted therapy
Published: February 08, 2020
Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells.
Journal: Molecular cancer
Published: October 26, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026